Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

脊髓灰质炎根除方面的进展.

P A Patriarca1, W H Foege, T A Swartz

  • 1National Vaccine Program Office, Rockville, Maryland.

Lancet (London, England)
|December 11, 1993
PubMed
概括

No abstract available in PubMed .

关键词:
提供医疗保健服务.疾病 疾病 疾病卫生健康 卫生健康 卫生健康卫生服务 卫生服务 卫生服务免疫接种 免疫接种国际机构 国际机构障碍物 这些障碍物组织与管理 组织与管理组织 组织 组织 组织初级医疗保健是一项主要的医疗保健服务.没有一个,没有一个,没有一个.疫苗 疫苗是一种疫苗.病毒性疾病 病毒性疾病谁是谁,谁是谁的人.世界世界世界世界世界世界世界.

相关实验视频

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Early results of an extensive rubella epidemic.

International journal of epidemiology·2013
Same author

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age.

Vaccine·2011
Same author

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.

Vaccine·2009
Same author

Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.

Vaccine·2008
Same author

Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up.

European journal of epidemiology·2003
Same author

Influenza surveillance during winter 1997-1998 in Israel.

The Israel Medical Association journal : IMAJ·2002
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
查看所有相关文章